|
Originally published In Press as doi:10.1074/jbc.M110226200 on December 21, 2001
J. Biol. Chem., Vol. 277, Issue 9, 7282-7286, March 1, 2002
Residues 137 and 153 at the N Terminus of the XylS Protein
Influence the Effector Profile of This Transcriptional Regulator and
the Factor Used by RNA Polymerase to Stimulate Transcription
from Its Cognate Promoter*
Raquel
Ruiz and
Juan L.
Ramos§
From the Department of Biochemistry and Molecular and Cellular
Biology of Plants, Estación Experimental del Zaidín,
Consejo Superior de Investigaciones Científicas, Apartado de
Correos 419, E-18008 Granada, Spain
Received for publication, October 24, 2001, and in revised form, December 21, 2001
 |
ABSTRACT |
The 321-residue XylS and XylS1 proteins, encoded
by the pWW0 and pWW53 plasmids respectively, differ in only 5 residues
at positions 4, 53, 90, 137, and 153. As a result, the effector profile of XylS is wider than that of XylS1, and XylS mediates higher levels of
transcription from its cognate-regulatable promoter than does XylS1. We
generated a series of XylS-pWW0 mutants and found that the single
mutants Asp-137 Glu and His-153 Asn exhibited an activation
pattern different from that of the wild-type regulator. In the
double-mutant XylSD137E,H153N the effector profile for benzoates was
similar to that of XylS1. This suggests that these two residues are
crucial for effector recognition and regulator activation to stimulate
transcription. XylS-dependent transcription from its
cognate promoter is mediated by RNA polymerase with
32 or 38, whereas XylS1 uses RNA
polymerase with 32 or 70. We also found
that point mutations at positions 137 and 153 of XylS led RNA
polymerase to mediate transcription with 70 rather than
with 38, as demonstrated by primer extension analysis in
a 70-thermosensitive background proficient and deficient
in 38. This suggests that a positive transcriptional
regulator can choose the RNA polymerase complex that mediates
transcription from a given promoter.
 |
INTRODUCTION |
Gene regulators respond to specific environmental, cellular, and
other signals by stimulating or inhibiting transcription, translation,
or some other event in gene expression so that the rate of synthesis of
the gene product is appropriately modified (1, 2). Research efforts in
our laboratory have focused on the regulation of the TOL
plasmid-encoded catabolic pathway for the metabolism of benzoate and
alkylbenzoates. Genes encoding the TOL meta-cleavage pathway
in pWW0 are grouped into a single operon whose expression is positively
regulated at the level of transcription by the xylS gene
product, which is activated by benzoate effectors (for review, see Ref.
3). Another well studied TOL plasmid is pWW53, which bears two
functional homologous meta-pathway operons, together with
two functional copies of the xylS regulatory genes
(xylS1 and xylS3) (4-7). XylS-pWW0 and
XylS1-pWW53 differ in five amino acids, whereas XylS3 shows conserved
sequence similarity with these two proteins only at their C-terminal
end (6, 7), where there is a bipartite DNA binding domain made of two
-helix-turn- -helix motifs (as in the MarA, Rob, and AraC
proteins) (8-11). All three XylS isoforms are able to stimulate
transcription from the Pm1
promoter (7).
We previously isolated XylS mutants with altered effector specificity
(i.e. Arg-45 Thr and Cys-41 Gly) or impaired
effector recognition (i.e. Arg-41 Leu) (12, 13). These
findings suggested that the amino-end part of XylS is involved in
effector recognition and XylS activation. XylS1-pWW53 and XylS-pWW0
differ in only 5 amino acids (Cys-4, Cys-53, Gly-90, Asp-137, and
His-153 in XylS versus Arg-4, Gly-53, Asp-90, Glu-137, and
Asn-153 in XylS1), but despite this minor difference the latter
exhibited a much narrower effector profile than XylS-pWW0 (7). In fact,
XylS1-pWW53 recognizes only 3MB and 3CB as effectors, whereas XylS-pWW0
recognizes in addition other alkyl- and chlorobenzoates with
substituents at positions 2 or 4 (14, 15). The difference in effector
profile is consistent with the changes occurring at the N-terminal end of these regulators.
Both XylS and XylS1 mediate transcription with RpoH ( 32)
in the early log phase (7, 16); however,
XylS-pWW0-dependent transcription from Pm is subsequently
mediated by RNA polymerase with 38 (16), whereas in the
case of XylS1 the factor used by RNA polymerase is
70 (7). Therefore, the minor differences at the protein
sequence level between the two XylS proteins also impose dependence on the used by RNA polymerase. In light of these effects we decided to
introduce stepwise mutations in XylS-pWW0 to determine their effects on
transcriptional activity of the mutants.
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains, Culture Medium, Plasmids, and Phages--
The
bacterial strains were Escherichia coli MC4100
(F , araD139 (argF-lac) U169
rpsL150 (Strr) relA1
flbB5301 deoC1 ptsF25
rbsR), E. coli RH90 (MC4100
rpoS59::Tn10) (17), E. coli
KY1429 (MC4100 rpoH6 [Am]
zhf-50::Tn10) (18), E. coli
P90A5c (thi lacZ4 argG75) (19), and E. coli UQ285
(thi lacZ4 argG75 rpoD285). This last strain has a short
deletion at the rpoD gene so that 70 is
nonfunctional at 42 °C (19). We also used E. coli EEZ286, an rpoS mutant of UQ285 constructed after P1 transduction
(20) of rpoS59::Tn10 into the UQ285
background (this study). Bacteria were grown at 30 °C in
Luria-Bertani medium supplemented, when required, with 100 µg/ml
ampicillin, 25 µg/ml kanamycin, 50 µg/ml streptomycin, 30 µg/ml
chloramphenicol, or 10 µg/ml tetracycline. Growth was determined
turbidometrically at 660 nm.
The following previously constructed plasmids were used. pCMX2 is a
tetracycline resistance derivative of pSELECT containing the entire
xylS gene inserted into the BamHI site (21).
pERD100 is an IncQ group plasmid that carries a fusion of Pm to a
promoterless 'lacZ gene and encodes resistance to
tetracycline (22). Plasmid pJLR107 has a 401-base pair PstI
fragment of the TOL plasmid containing the Pm promoter fused to a
promoterless 'lacZ gene in pMD1405 (pBR replicon) and
encodes resistance to ampicillin (23). pLOW2 is a pACYC177 derivative,
low copy number cloning vector that encodes resistance to kanamycin
(24).
DNA Techniques--
DNA preparation, digestion with restriction
enzymes, and analysis by agarose gel electrophoresis, isolation of DNA
fragments, ligations, transformations, transduction with P1 phage, and
sequencing reactions were done according to standard procedures (25) or to the manufacturer's recommendations.
Construction of xylS Mutants by PCR--
The xylS
mutants were generated by overlap extension PCR mutagenesis (26) with
internal oligonucleotide primers that exhibited one mismatch with
respect to the wild-type sequence. The external primers were
5'-GGCACTGGGATCGTTCAAGC-3' and 5'-GGATTTTTGCTTATTGAACG-3'. After DNA
amplification, the resulting DNA was digested with XhoI and
BglII, and the 761-base pair
XhoI-BglII xylS mutant fragments were
inserted between the XhoI-BglII sites of pCMX2 to
yield plasmids pCMX2::xylS* (the asterisk
indicates that one or more of the amino acids in the wild-type protein
has been changed). In a first round of mutagenesis we generated single
mutants at positions 4, 53, 90, 137, and 153 as indicated in Table I.
These single mutants were used to construct the double mutants shown in
Table I. All the xylS mutant alleles generated in this study
were verified by DNA sequencing. Plasmids
pCMX2::xylS* bearing the xylS* mutant alleles were digested with EcoRI and XbaI, and
the 1609-base pair EcoRI-XbaI fragments, which
contained the entire set of xylS* mutant alleles, were
subcloned between the EcoRI and XbaI sites of
pLOW2 to generate plasmids pLAR1 through 18, which encoded the mutant
XylS proteins shown in Table I.
-Galactosidase Assays--
E. coli bearing the
wild-type xylS allele or xylS mutant alleles in
pLARx (the x indicates a number between 1 and 18) plus pERD100 or
pJLR107 were grown overnight in Luria-Bertani medium containing the
appropriate antibiotics. Cultures were diluted 100-fold in the same
medium supplemented or not with 1 mM benzoate analog. After
5 h of incubation, -galactosidase activity was assayed in
permeabilized whole cells as described previously (26).
Western Blot Analysis--
Rabbit polyclonal antibodies against
the XylS protein were produced and used to detect XylS proteins
fractionated in SDS-PAGE gels with goat anti-rabbit antibodies
conjugated to peroxidase according to the protocol described by Jones
and Gregory (27).
RNA Preparation, Analysis, and Primer Extension--
RNA was
extracted with a modification of the guanidinium isothiocyanate-phenol
method (16). The RNA concentration was determined by measuring
A260. Hybridization of the
32P-5'-end-labeled single-stranded DNA primer
(105 cpm) complementary to the mRNA transcript produced
from the Pm promoter and primer extension with avian myeloblastosis
virus reverse transcriptase were done as described previously (16). In
all assays 20 µg of total RNA was used as the template. The oligonucleotide used in the reverse primer extension reactions was
5'-GATGTGCTGCAAGGCGATTAAGTTG-3'. cDNA products were analyzed in a
urea-polyacrylamide sequencing gel, and the intensities of the bands in
the autoradiography were densitometrically determined. All assays were
done at least three times, and nonsignificant differences were detected
in the levels of the different extended products.
 |
RESULTS |
Response of the XylS Mutant Regulators to Benzoates Substituted at
Position 3 on the Aromatic Ring--
The wild-type XylS regulator and
the series of single point mutant regulators constructed by overlapping
PCR mutagenesis were cloned in the low copy number plasmid pLOW2 as
described above. The resulting plasmids were transformed in E. coli MC4100 (pERD100), and -galactosidase activity in response
to the addition of 3MB was determined (Table
I). This benzoate analog was chosen in this first series of assays because it is the best effector for both
XylS-pWW0 and XylS1-pWW53. The level of transcription mediated by the
wild-type XylS-pWW0 increased about 40-fold with respect to the basal
level, whereas the XylS1-pWW53 protein mediated only a 4-fold
induction (Table I). Each of the single point mutants of XylS-pWW0 were
also assayed, and the results showed little effect for the changes
Cys-4 Arg, Cys-53 Gly, and Gly-90 Asp and a modest effect
for the point mutants Asp-137 Glu and His-153 Asn (the activity
decreased to about 50% that measured for the wild-type XylS-pWWO
protein) (Table I).
View this table:
[in this window]
[in a new window]
|
Table I
Induction ratio mediated by wild-type XylS-pWW0 and several single,
double, and triple mutants of this regulator with 3-methyl-, 3-chloro-
or 3-bromobenzoate as effectors
E. coli MC4100 bacteria that bear pERD100
(Pm::'lacZ) and pLOW2 (XylS) or pLRA-X (encoding for the
XylS mutants shown in the table) were grown on Luria-Bertani medium
with tetracycline and kanamycin. -Galactosidase activity was assayed
in permeabilized cells as described under "Experimental
Procedures." Induction ratio is defined as the enzyme level in cells
grown in the presence of the inducer to the level determined in cells
grown without an effector. Basal levels of -galactosidase were
between 30 and 50 Miller units in all cases. 3BrB, 3-bromobenzoate.
|
|
Given that the induction level mediated by XylS1 with 3MB was
significantly lower than in the single mutants, we generated all
possible double mutations. The level of induction of the double mutant
XylSD137E,H153N was similar to that of XylS1 (Table I). The combination
of either the Asp-137 Glu or His-153 Asn mutation with Cys-4
Arg resulted in levels of activity lower than that found with any
of the single mutants. However, when Asp-137 Glu or His-153 Asn
was combined with a mutation in position 53 or 90, the activity was
similar to that seen with the Asp-137 Glu or His-153 Asn
mutation alone (Table I).
This prompted us to analyze the combination of double mutant
XylSD137E,H153N with the rest of the mutations. The result was that
these mutants behaved like the double mutant and exhibited an induction
level similar to that determined with XylS1-pWW53 (Table I). These
results, therefore, suggest that residues 137 and 153 in XylS-pWW0 play
a key role in effector recognition and activation of this regulator.
To determine whether the effect of the mutations was specific for 3MB,
we tested the level of induction with two other substituted benzoate
analogs that are effectors of XylS-pWW0, 3CB and 3-bromobenzoate. In
general, 3CB and 3-bromobenzoate induced less -galactosidase activity than 3MB with any of the mutants, and the reduction in the
induction level for each of the mutants with these effectors followed a
pattern similar to the decreases observed with 3MB as the effector
(Table I).
In Vivo Stability of the Mutants--
To test whether the decrease
in activation reflected worse stability of the mutant proteins, we
performed Western blots with total protein from E. coli
bearing the XylS-pWW0 mutant alleles and used a polyclonal antibody
against the XylS protein. In all cases the amount of XylS mutant
protein was similar (not shown), and therefore, differences in
expression levels mediated by each mutant regulator from Pm cannot in
principle be ascribed to altered stability of the mutant proteins.
Effector Profile of the Mutant Regulators--
Based on the above
results we concentrated our efforts on the characterization of the
single XylSD137E and XylSH153N mutants and the double mutant
XylSD137E,H153N. We tested the effector profile of the mutant
regulators with all possible mono- and di-substituted methylbenzoates.
Fig. 1 shows the results for the
wild-type XylS-pWW0. The order of strength of inducibility was 3MB > 2,3DMB > B > 3,4DMB > 2MB = 4MB = 2,5DMB > 3,5DMB = 2,6DMB, with the last two
dimethylbenzoates being considered noneffectors for XylS. Fig. 1 shows
the induction profile of the single mutants XylSD137E and XylSH153N and
the double mutant XylSD137E,H153N. The two single mutants recognized most of the effectors, but as with the benzoates substituted at position 3, all mutants exhibited lower levels of induction than the
wild type. In contrast, the double mutant XylSD137E,H135N seemed not to
respond to 3,4DMB, 2MB, or 4MB and exhibited an effector profile
similar, if not identical, to that of the XylS1-pWW53 regulator (Fig.
1).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Induction mediated by XylS and mutant
derivatives with substituted benzoates. E. coli MC4100
bearing pERD100 (Pm::'lacZ) and pLAR1 (XylS)
( ), pLAR5 (XylSD137E) ( ), pLAR6 (XylSH153N)( ), and pLAR16
(XylSD137E, H153N) ( ) or pLAR32 (XylS1) ( ) were grown overnight
on Luria-Bertani medium with kanamycin and tetracycline. Cultures were
diluted 100-fold in the same medium but with 1 mM indicated
benzoate, and after 5 h, -galactosidase activity was assayed in
permeabilized cells. 2MB, 3MB, 4MB, 2-, 3-, and 4-methylbenzoate,
respectively; 2,3DMB and 3,4DMB, 2,3- and 3,4-dimethylbenzoate,
respectively; B, benzoate.
|
|
Characterization of a Collection of XylS Mutants at Positions 137 and 153--
To further confirm the crucial role of residues 137 and
153 of XylS-pWW0 in effector recognition and regulator activation, we
introduced as many mutations as possible by random overlapping mutagenesis at positions 137 and 153 in the XylS protein. We sequenced about 20 putative mutants for each position and found 5 new mutants at
position 137 (aspartic acid was replaced by glutamic acid, proline,
serine, arginine, and leucine) and two new mutants at position 153 (histidine was replaced by glycine and aspartic acid) (the mutant
proteins were shown to be stable as deduced from the level of protein
made by the cells and revealed by Western blot immunodetection of XylS
proteins). We determined -galactosidase expression from Pm mediated
by each mutant in response to a series of substituted benzoates.
Replacement of aspartic 137 with arginine or proline resulted in a
mutant regulator unable to stimulate transcription with any benzoate
effector (Table II), whereas replacement of aspartic acid by glutamic acid or serine reduced activation capacity
to about 50% that observed for the wild type. Replacement with apolar
leucine resulted in a mutant with very low activity. At position 153 replacement of histidine with glycine or aspartic acid resulted in
mutants that showed no activity (Table II). These results suggest that
residues 137 and 153 influence the ability of XylS to activate
transcription from Pm.
View this table:
[in this window]
[in a new window]
|
Table II
Effect of mutations at positions 137 and 153 of XylS on Vmax
induction from Pm
Conditions were as in Table 1, except that the XylS mutants were those
shown below. B, benzoate; 3BrB, 3-bromobenzoate.
|
|
Residues at the N Terminus of XylS Influence the Factor Used by
RNA Polymerase to Stimulate Transcription from Pm; in Vivo Evidence for
Transcription from Pm Mediated by RNA Polymerase with 70
by XylS-pWW0 Mutant Proteins--
Marqués et al. (16)
showed that 3MB induces the heat shock response upon addition to cell
cultures and that RNA polymerase uses 32 to mediate the
XylS1- and XylS-dependent expression from Pm. Once the
cultures reached the mid-log growth phase, RNA polymerase uses
38 to mediate transcription from Pm in the case of XylS
and 70 in the case of XylS1. We tested whether
transcription mediated by XylS mutants from a Pm:'lacZ
fusion followed the pattern of induction of the wild-type regulator
when induction was assayed in a 38-deficient background.
The results obtained confirmed that expression from Pm in the mid-log
growth phase mediated by XylS1 is 38-independent,
whereas transcription stimulation from Pm with the XylS regulator is
dependent on 38 (not shown). In contrast, in all three
mutants we tested, the dependence on 38 was lost. To
further confirm that the level of -galactosidase activity reflected
the transcriptional activity from Pm, we determined the level of
expression from Pm in different backgrounds by using 70ts mutants proficient and deficient in the synthesis
of 38. The parental strain of these isogenic strains is
E. coli P90A5c. This strain bearing the xylS or
xylS1 alleles is able to transcribe the Pm promoter in
response to the addition of 3MB regardless of the incubation
temperature, as expected (Fig.
2A). E. coli UQ285
has a 70ts that is thermosensitive at 42 °C. Because
expression from Pm with XylS seems to be dependent on 38
whereas with XylS1 it seems to depend on 70, one would
expect transcription from Pm to occur at 30 °C in UQ285 and at
42 °C with XylS and at 30° but not at 42 °C with XylS1. We
tested transcription from Pm in XylS- and XylS1-proficient backgrounds
in the absence and in the presence of 3MB. In these genetic
backgrounds, no transcription from Pm took place in the absence of the
effector (not shown). In the presence of 3MB, transcription occurred at
30 °C with either XylS or XylS1 (Fig. 2B), but at 42 °C transcription from Pm was seen only in the XylS-proficient background (Fig. 2B) (as a control of the correct
functioning of the UQ285 strain, note that transcription from
the 70 tandem Pr1 and Pr2 promoters occurred at 30 °C
but not at 42 °C (not shown)). We then tested transcription
stimulation from Pm at 30 °C and 42 °C with XylSD137E and
XylSH153N. The results obtained were similar with both mutants and are
shown for XylSD137E in Fig. 2B. XylSD137E behaved like XylS1
rather than like XylS; we interpret this result to indicate that
XylSD137E facilitated transcription from Pm with 70
rather than with 38 in the logarithmic growth phase.

View larger version (93K):
[in this window]
[in a new window]
|
Fig. 2.
In vivo transcription from
Pm mediated by XylS, XylS1, or XylSD137E in a
70- and
38-proficient strain and in a
70thermosensitive background
proficient and deficient in
38 synthesis at different
temperatures. E. coli P90A5c ( 70+,
38+) (panel A), E. coli UQ285
( 70ts, 38+) (panel B), and
E. coli EEZ286 ( 70ts, 38 )
(panel C) bearing pJLR107 (Pm::'lacZ)
and pLAR1(XylS) (lanes 1-3), pLAR18 (XylS1) (lanes
7-9), or pLAR5 (XylSD137E) (lanes 4-6) were
grown until the late exponential phase in the presence of 3MB at
30 °C. When the turbidity was ~1.2, a sample was withdrawn
for RNA extraction (lanes 1, 4, and
7), then each culture was divided into two halves. One was
kept as a control at 30 °C (lanes 2, 5, and
8), and the other was incubated at 42 °C
(lanes 3, 6, and 9), and after 45 min
RNA was extracted. Primer extension and separation of cDNA was done
as described under "Experimental Procedures."
|
|
To further confirm the switch in factors in RNA polymerase
to transcribe Pm depending on the regulator used, we constructed E. coli EEZ286, which in addition to the 70ts
mutation has an inactive 38 allele. In this mutant
background, transcription from Pm did not occur in the absence of 3MB;
however, in the presence of the effector and in cultures incubated at
30 °C, transcription from Pm took place in the XylS1 background but
not in the XylS background (Fig. 2C). Mutants XylSD137E and
XylSH153N, in contrast with XylS, were able to stimulate transcription
from Pm, as shown for XylSD137E in Fig. 2C.
 |
DISCUSSION |
XylS and XylS1 are 98.44% identical and differ in only 5 of 321 residues, all of which are located in the N-terminal end. The
availability of these two different alleles of the regulator is of
great interest, because these "minor" differences are clearly reflected in the regulator ability to induce transcription from Pm with
different effectors and in the interactions with the transcriptional machinery. With regard to the kinetic properties, Gallegos et al. (7) first reported that the induction rate from Pm in the XylS-pWW0 regulator was about 6-10-fold as high as that in XylS1 and
that XylS-pWW0 regulator had a wider effector profile than XylS1-pWW53.
The introduction of stepwise mutations in XylS-pWW0 revealed that the
single mutations with the greatest effect on the degree of
transcriptional activation and the effector profile were those that
involved residues 137 or 153. This was further confirmed when the
effector profile for effectors in the double mutant XylSD137E,H153N
were found to be similar to those of the XylS1-pWW53 regulator. This
indicated that these residues may be involved in effector interactions.
The importance of the involvement of residues 137 and 153 in
interactions with effectors was confirmed when random mutations at
these positions resulted in point mutants (i.e. XylSD137R, XylSD137P, XylSH153G, and XylSH153D) that had lost the ability to
recognize effectors. Recently the MarR regulator, which recognizes 2-hydroxybenzoate (salicylate) as an effector, has been crystallized with the aromatic carboxylic acid (28). In this regulator salicylate is
bound in two sites, SalA and SalB; in both sites the salicylate carboxylate hydrogen bound to the positively charged lateral chain of
arginine residues. The salicylate hydroxyl group is hydrogen-bound to
the hydroxyl chain of a threonine at the SalA site and to the backbone
carboxyl of an alanine at the SalB site. This indicates that
substituents on the aromatic ring can establish interactions with
different residues. On the basis of these results it is tempting to
speculate that in XylS, histidine 153 might be involved in interactions
with substituents on the benzoate aromatic ring, because mutations in
this residue to uncharged or negatively charged amino acids resulted in
loss of the ability to recognize benzoate derivatives. This in turn may
be due to loss of interactions with the carboxyl group. The change
His-153 Asn resulted in a less efficient regulator, but the amide
lateral chain of glutamine may allow certain interactions with benzoate derivatives.
Given the negative character of aspartic acid 137, this residue cannot
be involved in interactions with the carboxyl chain of benzoate.
Instead, residue aspartic acid 137 may be involved in other
interactions with substituents or in the intramolecular signal
transmission chain that leads to activation of the regulator. In fact,
altering the charge of this residue influenced the ability of the
regulator to recognize benzoates.
Our previous study revealed cysteine 41 as another amino acid that may
be part of the XylS effector pocket. The phenotype of mutants XylSD137R
and XylSH153G regarding the lost ability to recognize benzoates is
similar to the one we found when cysteine 41 was replaced with leucine
(12). However, at position 41, certain mutations resulted in other
phenotypic changes. For example, replacement of cysteine 41 with
arginine resulted in a mutant that exhibited a semiconstitutive
phenotype (i.e. it mediated a high level of transcription
from Pm in the absence of effectors). Mutant XylSC41G showed altered
effector specificity; it did not recognize 4MB but retained the ability
to recognize 3MB (12). That different mutations in positions 41, 137, and 153 give rise to different phenotypes is consistent with the
different roles of residues 41, 137, and 153 in interactions with
effectors or signal transmission to achieve the active form of this
transcriptional regulator. However, whether any of these residues
interacts with the effectors is still unknown. Details of these
interactions await resolution of the three-dimensional structure of
this regulator with and without the effector.
The XylS protein has so far been difficult to purify because of the
intrinsic insolubility of the protein, a characteristic shared by many
proteins of the XylS/AraC family of regulators (29-31). However, we
recently solubilized the N-terminal end of XylS upon fusion to MalE and
are now trying to obtain further insights into the structural
characteristics of the N-terminal end of
XylS.2
Two members of the XylS family, SoxS and MarA, which are about 110 amino acid long, are equivalent to the C terminus of the XylS family of
proteins. This coincidence suggests that the C-terminal end in members
of the XylS/AraC family is involved in DNA binding and probably in
interactions with the transcriptional machinery. A study by
Michán et al. (31) shows that although the N and C
termini of XylS have specific functions, they are not independent, and
they cross-talk. Their relationship is further supported by the present
finding that mutations at the N terminus influence which factor the
RNA polymerase chooses to stimulate transcription from Pm. In fact, the
Pm promoter is unique in that XylS-dependent transcription
from Pm requires RNA polymerase with either 32 or
38, whereas XylS1 uses 32 or
70 with RNA polymerase. 3-Methylbenzoate induces the
heat shock response (16), and upon initial transcription with
32, this factor is replaced by 38 for
XylS and 70 for XylS1. It is also interesting to note
that minor changes in XylS influence the preferred factor that RNA
polymerase chooses for transcription from Pm. Single point mutations at
positions 137 and 153 of XylS are sufficient to allow RNA polymerase to function with 70 instead of 38. As
described under "Results," the transcription initiation point from
Pm is the same regardless of the factor RNA polymerase used to
transcribe the Pm promoter, and although 70 and
38 belong to the same class of factor (32-35), it
is likely that RNA polymerase with different factors recognizes
different nucleotides at the 10 and 35 boxes in Pm.
In summary, XylS1 and XylS are almost identical, differing in only five
residues. Two of the five amino acids, at positions 137 and 153, had
major effects on effector recognition and significantly influenced the
effector pattern. These residues in XylS also influence whether XylS
mediates transcription from Pm with RNA polymerase using either
70 or 38. Further studies with this
system are expected to reveal the mechanisms by which subtle changes in
XylS can influence transcription from Pm to such a significant degree.
 |
ACKNOWLEDGEMENTS |
We thank Silvia Marqués for critical
reading of the manuscript, Marian Guerrero for technical assistance, M. Mar Fandila and Carmen Lorente for secretarial assistance, and Karen
Shashok for improving the English.
 |
FOOTNOTES |
*
This study was supported by European Commission Grant
QLK3-2000-0170 and the Spanish Comisión Interministerial de
Ciencia y Tecnología Grant BIO2000-0964.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a fellowship from the Spanish Ministry of Education
and Culture.
§
To whom correspondence should be addressed. Tel: 34-958-121011;
Fax: 34-958-129600; E-mail: jlramos@eez.csic.es.
Published, JBC Papers in Press, December 21, 2001, DOI 10.1074/jbc.M110226200
2
R. Ruíz, S. Marqués, and J. L. Ramos, unpublished information.
 |
ABBREVIATIONS |
The abbreviations used are:
Pm, promoter for the
TOL meta-cleavage pathway;
CB, chlorobenzoate;
MB, methylbenzoate;
DMB, dimethylbenzoate.
 |
REFERENCES |
| 1.
|
Ebright, R. H.,
and Busby, S.
(1995)
Curr. Opin. Genet. Dev.
5,
197-203[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Ramos, J. L.,
Gallegos, M. T.,
Marqués, S.,
Ramos-González, M. I.,
Espinosa-Urgel, M.,
and Segura, A.
(2001)
Curr. Opin. Microbiol.
4,
166-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Ramos, J. L.,
Marqués, S.,
and Timmis, K. N.
(1997)
Annu. Rev. Microbiol.
31,
341-374[CrossRef]
|
| 4.
|
Keil, S.,
Pickup, R. W.,
and Williams, P. A.
(1985)
J. Bacteriol.
164,
887-895[Abstract/Free Full Text]
|
| 5.
|
Osborne, D. J.,
Pickup, R. W.,
and Williams, P. A.
(1988)
J. Gen. Microbiol.
134,
2965-2975[Abstract/Free Full Text]
|
| 6.
|
Assinder, S. J.,
and Williams, P. A.
(1988)
J. Gen. Microbiol.
134,
2769-2778[Abstract/Free Full Text]
|
| 7.
|
Gallegos, M. T.,
Williams, P. A.,
and Ramos, J. L.
(1997)
J. Bacteriol.
179,
5024-5029[Abstract/Free Full Text]
|
| 8.
|
Rhee, S.,
Martin, R. G.,
Rosner, J. L.,
and Davies, D. R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10413-10418[Abstract/Free Full Text]
|
| 9.
|
Kwon, H. J.,
Bennik, M. H. J.,
Demple, B.,
and Ellenberger, T.
(2000)
Nat. Struct. Biol.
7,
424-430[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Brunelle, A.,
and Schleif, R.
(1989)
J. Mol. Biol.
209,
606-622
|
| 11.
|
Niland, P.,
Hühne, R.,
and Müller-Hill, B.
(1996)
J. Mol. Biol.
264,
667-674[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Michán, C.,
Zhou, L.,
Gallegos, M. T.,
Timmis, K. N.,
and Ramos, J. L.
(1992)
J. Biol. Chem.
267,
22897-22901[Abstract/Free Full Text]
|
| 13.
|
Ramos, J. L.,
Michán, C.,
Rojo, F.,
Dwyer, D.,
and Timmis, K. N.
(1990)
J. Mol. Biol.
211,
373-382[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Ramos, J. L.,
Stolz, A.,
Reineke, W.,
and Timmis, K. N.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8467-8471[Abstract/Free Full Text]
|
| 15.
|
Gallegos, M. T.,
Marqués, S.,
and Ramos, J. L.
(1996)
J. Bacteriol.
178,
6427-6434[Abstract/Free Full Text]
|
| 16.
|
Marqués, S.,
Manzanera, M.,
González-Pérez, M. M.,
Gallegos, M. T.,
and Ramos, J. L.
(1999)
Mol. Microbiol.
31,
1105-1113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Lange, R.,
and Hengge-Aronis, R.
(1991)
Mol. Microbiol.
5,
49-59[Medline]
[Order article via Infotrieve]
|
| 18.
|
Zhou, Y.-N.,
Kusukawa, N.,
Erickson, J. W.,
Gross, C.,
and Yura, T.
(1988)
J. Bacteriol.
170,
3640-3649[Abstract/Free Full Text]
|
| 19.
|
Harris, J. D.,
Heilig, J. S.,
Martínez, I. I.,
Calendar, R.,
and Isaksson, L. A.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
6177-6181[Abstract/Free Full Text]
|
| 20.
|
Goldberg, R. B.,
Bender, R. A.,
and Streicher, S. L.
(1974)
J. Bacteriol.
118,
810-814[Abstract/Free Full Text]
|
| 21.
|
Manzanera, M.,
Marqués, S.,
and Ramos, J. L.
(2000)
FEBS Lett.
476,
312-317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Egan, S. M.,
Pease, A. J.,
Lang, J., Li, X.,
Rao, V.,
Gillete, W. K.,
Ruíz, R.,
Ramos, J. L.,
and Wolf, R. E., Jr.
(2000)
J. Bacteriol.
182,
7075-7077[Abstract/Free Full Text]
|
| 23.
|
Ruíz, R.,
Ramos, J. L.,
and Egan, S. M.
(2001)
FEBS Lett.
491,
207-211[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Hansen, L. H.,
Sorensen, S. J.,
and Jensen, L. B.
(1997)
Gene
186,
167-173[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1991)
Current Protocols in Molecular Biology
, John Wiley & Sons, Inc., New York
|
| 26.
|
González-Pérez, M. M.,
Ramos, J. L.,
Gallegos, M. T.,
and Marqués, S.
(1999)
J. Biol. Chem.
274,
2286-2290[Abstract/Free Full Text]
|
| 27.
|
Jones, E. L.,
and Gregory, J.
(1989)
Antibodies: A Practical Approach
, Vol. II
, pp. 155-178, IRL Press at Oxford University Press, Oxford
|
| 28.
|
Alekshun, M. N.,
Levy, S. B.,
Mealy, T. R.,
and Seaton, B. A.
(2001)
Nat. Struct. Biol.
8,
710-714[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Egan, S. M.,
and Schleif, R. F.
(1994)
J. Mol. Biol.
243,
821-829[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Fawcett, W. P.,
and Wolf, R. E.
(1994)
Mol. Microbiol.
14,
669-679[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Michán, C.,
Kessler, B.,
de Lorenzo, V.,
Timmis, K. N.,
and Ramos, J. L.
(1992)
Mol. Gen. Genet.
235,
406-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Ishihama, A.
(2000)
Annu. Rev. Microbiol.
54,
499-518[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Arthur, T. M.,
and Burgess, R. R.
(1998)
J. Biol. Chem.
273,
31381-31387[Abstract/Free Full Text]
|
| 34.
|
Ohnuma, M.,
Fujita, N.,
Akira,
Tanaka, K.,
and Takahashi, H.
(2000)
J. Bacteriol.
182,
4628-4631[Abstract/Free Full Text]
|
| 35.
|
Owens, J. T.,
Miyake, R.,
Murakami, K.,
Chmura, A. J.,
Fujita, N.,
Ishihama, A.,
and Meares, C. F.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6021-6026[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Dominguez-Cuevas, P. Marin, S. Busby, J. L. Ramos, and S. Marques
Roles of Effectors in XylS-Dependent Transcription Activation: Intramolecular Domain Derepression and DNA Binding
J. Bacteriol.,
May 1, 2008;
190(9):
3118 - 3128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dominguez-Cuevas, P. Marin, J. L. Ramos, and S. Marques
RNA Polymerase Holoenzymes Can Share a Single Transcription Start Site for the Pm Promoter: CRITICAL NUCLEOTIDES IN THE -7 TO-18 REGION ARE NEEDED TO SELECT BETWEEN RNA POLYMERASE WITH {sigma}38 OR {sigma}32
J. Biol. Chem.,
December 16, 2005;
280(50):
41315 - 41323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tropel and J. R. van der Meer
Bacterial Transcriptional Regulators for Degradation Pathways of Aromatic Compounds
Microbiol. Mol. Biol. Rev.,
September 1, 2004;
68(3):
474 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lessner, R. E. Parales, S. Narayan, and D. T. Gibson
Expression of the Nitroarene Dioxygenase Genes in Comamonas sp. Strain JS765 and Acidovorax sp. Strain JS42 Is Induced by Multiple Aromatic Compounds
J. Bacteriol.,
July 1, 2003;
185(13):
3895 - 3904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ruiz, S. Marques, and J. L. Ramos
Leucines 193 and 194 at the N-Terminal Domain of the XylS Protein, the Positive Transcriptional Regulator of the TOL meta-Cleavage Pathway, Are Involved in Dimerization
J. Bacteriol.,
May 15, 2003;
185(10):
3036 - 3041.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|